Louise M. Goodwin

Design and synthesis of novel lactate dehydrogenase A inhibitors by fragment-based lead generation.

Jon Winter, David Whittaker, Gareth Davies, 2012, Journal of medicinal chemistry.

A pilot evaluation of the use of tissue microarrays for quantitation of target distribution in drug discovery pathology.

J. S. McKay, Alison L. Bigley, Louise M. Goodwin, 2006, Experimental and toxicologic pathology : official journal of the Gesellschaft fur Toxikologische Pathologie.

Pharmacology of the ATM inhibitor AZD0156: potentiation of irradiation and olaparib responses pre-clinically. ATM inhibitor AZD0156 potentiates IR and olaparib response.

B. Barlaam, E. Cadogan, G. Hughes, 2019 .

Acetyl-CoA Synthetase 2 Promotes Acetate Utilization and Maintains Cancer Cell Growth under Metabolic Stress

A. Harris, B. Spencer‐Dene, G. Stamp, 2015, Cancer cell.

Potent and Selective Inhibitors of MTH1 Probe Its Role in Cancer Cell Survival.

Graeme Walker, Lisa Wissler, Jon Read, 2016, Journal of medicinal chemistry.

Identification of DYRK1B as a substrate of ERK1/2 and characterisation of the kinase activity of DYRK1B mutants from cancer and metabolic syndrome

S. Cook, Mark Cockerill, T. Dunkley, 2015, Cellular and Molecular Life Sciences.

Pharmacology of the ATM Inhibitor AZD0156: Potentiation of Irradiation and Olaparib Responses Preclinically

M. O’Connor, B. Barlaam, E. Cadogan, 2019, Molecular Cancer Therapeutics.

Identification of DYRK1B as a substrate of ERK1/2 and characterisation of the kinase activity of DYRK1B mutants from cancer and metabolic syndrome

S. Cook, Mark Cockerill, T. Dunkley, 2015, Cellular and Molecular Life Sciences.

Discovery and optimization of a novel series of Dyrk1B kinase inhibitors to explore a MEK resistance hypothesis.

Mark Cockerill, J. Debreczeni, S. Guichard, 2015, Journal of medicinal chemistry.